Literature DB >> 20488023

Functional differentiation of a human ganglion cell derived neuroblastoma cell line SH-SY5Y induced by a phorbol ester (TPA).

K E Akerman1, I G Scott, L C Andersson.   

Abstract

When the human neuroblastoma cell line SH-SY5Y is exposed to 12-o-tetradecanoyl-phorbol-13-acetate (TPA) the cells grow long processes indicative of neural differentiation. Concomitantly there is an increase in the resting membrane potential from ?44 +/- 2 mV found in untreated cells to ?63 +/- 4 mV after induction. The TPA treated cells are depolarized when the external potassium concentration is increased to 46 mM and upon addition of veratridine. In contrast to the untreated cells depolarization in differentiated cells leads to an increase in the rate of Ca(2+) influx. This increase in Ca(2+) influx is blocked by the Ca(2+) channel antagonist, verapamil, while the Na(+) channel blocker tetrodotoxin only marginally inhibits the K(+) depolarization-induced Ca(2+) influx. The results suggest that the induction of morphological differentiation in this cell line is associated with the appearance of features of excitable cells.

Entities:  

Year:  1984        PMID: 20488023     DOI: 10.1016/0197-0186(84)90029-9

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  3 in total

1.  Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells.

Authors:  E P Seward; G Henderson
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

2.  The phorbolester TPA dramatically accelerates oligodendroglial process regeneration.

Authors:  J Schröter; H H Althaus
Journal:  Naturwissenschaften       Date:  1987-08

Review 3.  Modeling blood-brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms.

Authors:  Anuska V Andjelkovic; Svetlana M Stamatovic; Chelsea M Phillips; Gabriela Martinez-Revollar; Richard F Keep
Journal:  Fluids Barriers CNS       Date:  2020-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.